Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Extracellular vesicle fibrinogen induces encephalitogenic CD8+ T cells in a mouse model of multiple sclerosis.

Willis CM, Nicaise AM, Menoret A, Ryu JK, Mendiola AS, Jellison ER, Givogri MI, Han DK, Bongarzone ER, Akassoglou K, Vella AT, Crocker SJ.

Proc Natl Acad Sci U S A. 2019 May 21;116(21):10488-10493. doi: 10.1073/pnas.1816911116. Epub 2019 May 8.

2.

Costimulation Induces CD4 T Cell Antitumor Immunity via an Innate-like Mechanism.

Morales Del Valle C, Maxwell JR, Xu MM, Menoret A, Mittal P, Tsurutani N, Adler AJ, Vella AT.

Cell Rep. 2019 Apr 30;27(5):1434-1445.e3. doi: 10.1016/j.celrep.2019.04.016.

3.

Single cell transcriptomics based-MacSpectrum reveals novel macrophage activation signatures in diseases.

Li C, Menoret A, Farragher C, Ouyang Z, Bonin C, Holvoet P, Vella AT, Zhou B.

JCI Insight. 2019 Apr 16;5. pii: 126453. doi: 10.1172/jci.insight.126453.

4.

Direct CD137 costimulation of CD8 T cells promotes retention and innate-like function within nascent atherogenic foci.

Xu MM, Ménoret A, Nicholas SE, Günther S, Sundberg EJ, Zhou B, Rodriguez A, Murphy PA, Vella AT.

Am J Physiol Heart Circ Physiol. 2019 Jun 1;316(6):H1480-H1494. doi: 10.1152/ajpheart.00088.2019. Epub 2019 Apr 12.

PMID:
30978132
5.

Gasdermin D Restrains Type I Interferon Response to Cytosolic DNA by Disrupting Ionic Homeostasis.

Banerjee I, Behl B, Mendonca M, Shrivastava G, Russo AJ, Menoret A, Ghosh A, Vella AT, Vanaja SK, Sarkar SN, Fitzgerald KA, Rathinam VAK.

Immunity. 2018 Sep 18;49(3):413-426.e5. doi: 10.1016/j.immuni.2018.07.006. Epub 2018 Aug 28.

6.

T cell-directed IL-17 production by lung granular γδ T cells is coordinated by a novel IL-2 and IL-1β circuit.

Ménoret A, Buturla JA, Xu MM, Svedova J, Kumar S, Rathinam VAK, Vella AT.

Mucosal Immunol. 2018 Sep;11(5):1398-1407. doi: 10.1038/s41385-018-0037-0. Epub 2018 Jun 15.

7.

A novel biologic platform elicits profound T cell costimulatory activity and antitumor immunity in mice.

Ryan JM, Mittal P, Menoret A, Svedova J, Wasser JS, Adler AJ, Vella AT.

Cancer Immunol Immunother. 2018 Apr;67(4):605-613. doi: 10.1007/s00262-018-2116-1. Epub 2018 Jan 11.

8.

A Refined Bead-Free Method to Identify Astrocytic Exosomes in Primary Glial Cultures and Blood Plasma.

Willis CM, Ménoret A, Jellison ER, Nicaise AM, Vella AT, Crocker SJ.

Front Neurosci. 2017 Jun 15;11:335. doi: 10.3389/fnins.2017.00335. eCollection 2017.

9.

Therapeutic blockade of CD54 attenuates pulmonary barrier damage in T cell-induced acute lung injury.

Svedova J, Ménoret A, Mittal P, Ryan JM, Buturla JA, Vella AT.

Am J Physiol Lung Cell Mol Physiol. 2017 Jul 1;313(1):L177-L191. doi: 10.1152/ajplung.00050.2017. Epub 2017 May 4.

10.

Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production.

Shinde P, Liu W, Ménoret A, Luster AD, Vella AT.

J Leukoc Biol. 2017 Jul;102(1):57-69. doi: 10.1189/jlb.1A0616-261RR. Epub 2017 Apr 21.

11.
12.

Characterizing the inflammatory response in esophageal mucosal biopsies in children with eosinophilic esophagitis.

Sayej WN, Ménoret A, Maharjan AS, Fernandez M, Wang Z, Balarezo F, Hyams JS, Sylvester FA, Vella AT.

Clin Transl Immunology. 2016 Jul 1;5(7):e88. doi: 10.1038/cti.2016.30. eCollection 2016 Jul.

14.

Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis.

Tsurutani N, Mittal P, St Rose MC, Ngoi SM, Svedova J, Menoret A, Treadway FB, Laubenbacher R, Suárez-Ramírez JE, Cauley LS, Adler AJ, Vella AT.

J Immunol. 2016 Jan 1;196(1):124-34. doi: 10.4049/jimmunol.1501217. Epub 2015 Nov 16.

15.

Trace Levels of Staphylococcal Enterotoxin Bioactivity Are Concealed in a Mucosal Niche during Pulmonary Inflammation.

Ménoret A, Svedova J, Behl B, Vella AT.

PLoS One. 2015 Oct 28;10(10):e0141548. doi: 10.1371/journal.pone.0141548. eCollection 2015.

16.

Transition from identity to bioactivity-guided proteomics for biomarker discovery with focus on the PF2D platform.

Ménoret A, Crocker SJ, Rodriguez A, Rathinam VA, Clark RB, Vella AT.

Proteomics Clin Appl. 2016 Jan;10(1):8-24. doi: 10.1002/prca.201500029. Epub 2015 Sep 16. Review.

17.

Responses to LPS boost effector CD8 T-cell accumulation outside of signals 1 and 2.

Liu W, Menoret A, Vella AT.

Cell Mol Immunol. 2017 Mar;14(3):254-253. doi: 10.1038/cmi.2015.69. Epub 2015 Jul 20.

19.

Distinctive colonic mucosal cytokine signature in new-onset, untreated pediatric Crohn disease.

Sylvester FA, Draghi A, Menoret A, Fernandez ML, Wang Z, Vella AT.

J Pediatr Gastroenterol Nutr. 2014 Nov;59(5):553-61. doi: 10.1097/MPG.0000000000000480.

PMID:
25000355
20.

Rapid αβ T-cell responses orchestrate innate immunity in response to Staphylococcal enterotoxin A.

Kumar S, Colpitts SL, Ménoret A, Budelsky AL, Lefrancois L, Vella AT.

Mucosal Immunol. 2013 Sep;6(5):1006-15. doi: 10.1038/mi.2012.138. Epub 2013 Jan 16.

21.

Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells.

Ménoret A, Drew DA, Miyamoto S, Nakanishi M, Vella AT, Rosenberg DW.

Mol Carcinog. 2014 Feb;53 Suppl 1:E11-22. doi: 10.1002/mc.21986. Epub 2012 Dec 19.

PMID:
23255428
23.

Cytochrome b5 and cytokeratin 17 are biomarkers in bronchoalveolar fluid signifying onset of acute lung injury.

Ménoret A, Kumar S, Vella AT.

PLoS One. 2012;7(7):e40184. doi: 10.1371/journal.pone.0040184. Epub 2012 Jul 6.

24.

Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness.

Ngoi SM, St Rose MC, Menoret AM, Smith DE, Tovey MG, Adler AJ, Vella AT.

Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10486-91. doi: 10.1073/pnas.1202607109. Epub 2012 Jun 11.

25.
27.

CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.

Qui HZ, Hagymasi AT, Bandyopadhyay S, St Rose MC, Ramanarasimhaiah R, Ménoret A, Mittler RS, Gordon SM, Reiner SL, Vella AT, Adler AJ.

J Immunol. 2011 Oct 1;187(7):3555-64. doi: 10.4049/jimmunol.1101244. Epub 2011 Aug 31.

28.

Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity.

Nakanishi M, Menoret A, Tanaka T, Miyamoto S, Montrose DC, Vella AT, Rosenberg DW.

Cancer Prev Res (Phila). 2011 Aug;4(8):1198-208. doi: 10.1158/1940-6207.CAPR-11-0188. Epub 2011 May 16.

29.

The systemic and pulmonary immune response to staphylococcal enterotoxins.

Kumar S, Ménoret A, Ngoi SM, Vella AT.

Toxins (Basel). 2010 Jul;2(7):1898-912. doi: 10.3390/toxins2071898. Epub 2010 Jul 21. Review.

31.
32.

The oxazolidinone derivative locostatin induces cytokine appeasement.

Ménoret A, McAleer JP, Ngoi SM, Ray S, Eddy NA, Fenteany G, Lee SJ, Rossi RJ, Mukherji B, Allen DL, Chakraborty NG, Vella AT.

J Immunol. 2009 Dec 1;183(11):7489-96. doi: 10.4049/jimmunol.0901414. Epub 2009 Nov 16.

33.

Utilizing endoscopic technology to reveal real-time proteomic alterations in response to chemoprevention.

Nakanishi M, Ménoret A, Belinsky GS, Giardina C, Godman CA, Vella AT, Rosenberg DW.

Proteomics Clin Appl. 2007 Dec;1(12):1660-6. doi: 10.1002/prca.200700545.

PMID:
21136663
34.

Heat shock up-regulates lmp2 and lmp7 and enhances presentation of immunoproteasome-dependent epitopes.

Callahan MK, Wohlfert EA, Ménoret A, Srivastava PK.

J Immunol. 2006 Dec 15;177(12):8393-9.

35.

TGFbeta protein processing and activity through TCR triggering of primary CD8+ T regulatory cells.

Ménoret A, Myers LM, Lee SJ, Mittler RS, Rossi RJ, Vella AT.

J Immunol. 2006 Nov 1;177(9):6091-7.

36.

Inducible heat shock protein 70 expression as a potential predictive marker of metastasis in breast tumors.

Torronteguy C, Frasson A, Zerwes F, Winnikov E, da Silva VD, Ménoret A, Bonorino C.

Cell Stress Chaperones. 2006 Spring;11(1):34-43.

37.

Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia.

Li Z, Qiao Y, Liu B, Laska EJ, Chakravarthi P, Kulko JM, Bona RD, Fang M, Hegde U, Moyo V, Tannenbaum SH, Ménoret A, Gaffney J, Glynn L, Runowicz CD, Srivastava PK.

Clin Cancer Res. 2005 Jun 15;11(12):4460-8.

38.

Purification of recombinant and endogenous HSP70s.

Ménoret A.

Methods. 2004 Jan;32(1):7-12.

PMID:
14624870
39.

Hsp70, an immunological actor playing with the intracellular self under oxidative stress.

Ménoret A, Chaillot D, Callahan M, Jacquin C.

Int J Hyperthermia. 2002 Nov-Dec;18(6):490-505. Review.

PMID:
12537750
40.

Differential acquisition of antigenic peptides by Hsp70 and Hsc70 under oxidative conditions.

Callahan MK, Chaillot D, Jacquin C, Clark PR, Ménoret A.

J Biol Chem. 2002 Sep 13;277(37):33604-9. Epub 2002 Jul 11.

41.

Roles of heat-shock proteins in antigen presentation and cross-presentation.

Li Z, Menoret A, Srivastava P.

Curr Opin Immunol. 2002 Feb;14(1):45-51. Review.

PMID:
11790532
42.

The inducible Hsp70 as a marker of tumor immunogenicity.

Clark PR, Ménoret A.

Cell Stress Chaperones. 2001 Apr;6(2):121-5.

43.

Immunological properties of heat shock proteins are phylogenetically conserved.

Robert J, Ménoret A, Srivastava PK, Cohen N.

Adv Exp Med Biol. 2001;484:237-49. Review. No abstract available.

PMID:
11418990
44.

An endoplasmic reticulum protein implicated in chaperoning peptides to major histocompatibility of class I is an aminopeptidase.

Ménoret A, Li Z, Niswonger ML, Altmeyer A, Srivastava PK.

J Biol Chem. 2001 Sep 7;276(36):33313-8. Epub 2001 Jun 7.

45.

Phylogenetic conservation of the molecular and immunological properties of the chaperones gp96 and hsp70.

Robert J, Ménoret A, Basu S, Cohen N, Srivastava PR.

Eur J Immunol. 2001 Jan;31(1):186-95.

46.
47.
48.

Purification of multiple heat shock proteins from a single tumor sample.

Ménoret A, Bell G.

J Immunol Methods. 2000 Apr 3;237(1-2):119-30.

PMID:
10725457
49.
50.

Association of peptides with heat shock protein gp96 occurs in vivo and not after cell lysis.

Ménoret A, Peng P, Srivastava PK.

Biochem Biophys Res Commun. 1999 Sep 7;262(3):813-8.

PMID:
10471407

Supplemental Content

Loading ...
Support Center